PapersPMID:30541572
Efficacy of a nootropic spearmint extract on reactive agility: a randomized, double-blind, placebo-controlled, parallel trial.
- findings
- 2
- compound
- 1
- endpoints
- 2
- no difference found
- 1
- Study, every finding
- RCT
- Dose studied, every finding
- 900 mg/day (two capsules each morning with breakfast) for 90 days
What moved
How to read these marks →“Differences at baseline (p = 0.03) were present for CRP; therefore, ANCOVA was utilized to identify a significant treatment x visit interaction (p = 0.049) and pairwise comparisons revealed that PSE significantly decreased CRP at Day 30 compared to PLA (p = 0.045).”
- Duration
- 4 weeks
- Interests
- An author is affiliated with a producer
- Population
- Healthy, recreationally active men and women aged 18-50 years; Day 30 timepoint
What did not
“Comparisons between PSE and PLA were not significantly different for cortisol and IL6.”
- Duration
- 3 months
- Interests
- An author is affiliated with a producer
- Population
- Healthy, recreationally active men and women aged 18-50 years; all timepoints (Days 0, 7, 30, 90)
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- healthy, recreationally-active men and women aged 18–50 years; proprietary spearmint extract (PSE) 900 mg/day vs placebo
- Participants
- 142
- Comparator
- placebo
- Duration
- 90 days
- Endpoints measured
- 80